Phathom Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Phathom Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $625k | 100k | 6.27 |
| 2024-12-31 | $957k | 118k | 8.12 |
| 2024-09-30 | $1.8M | 98k | 18.08 |
| 2024-06-30 | $960k | 93k | 10.30 |
| 2024-03-31 | $137k | 13k | 10.62 |
| 2023-12-31 | $118k | 13k | 9.13 |
| 2021-09-30 | $241k | 7.5k | 32.10 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas